![discount label](https://static.cymitquimica.com/public/img/discount.png)
N-Hydroxy-4-(Trifluoromethyl)-Benzenecarboximidamide
CAS : 22179-86-8
Ref. 3D-FH92930
1g | À demander | ||
2g | À demander | ||
5g | À demander | ||
10g | À demander | ||
25g | À demander |
Informations sur le produit
- 4-(Trifluoromethyl)-N′-hydroxybenzenecarboximidamide
- 4-Trifluoromethylbenzamide Oxime
- 4-Trifluoromethylbenzamidoxime
- Benzenecarboximidamide, N-hydroxy-4-(trifluoromethyl)-
- N'-hydroxy-4-(trifluoromethyl)benzenecarboximidamide
- N-Hydroxy-4-(trifluoromethyl)benzamidine
- N-Hydroxy-4-trifluoromethylbenzimidamide
- p-Toluamidoxime, α,α,α-trifluoro-
N-hydroxy-4-(trifluoromethyl)benzenecarboximidamide (NHTB) is an experimental drug that has been shown to cause a significant decrease in tumor size and weight in xenograft models of cancer. NHTB selectively inhibits the enzyme glutamine synthetase, which is responsible for synthesizing the amino acid glutamate. This inhibition leads to a depletion of cellular energy and the death of cancer cells. NHTB also has immunosuppressive effects, which may be due to its ability to inhibit T cell proliferation. NHTB is currently being researched as a possible treatment for orotic aciduria and creatine deficiency syndrome.
Propriétés chimiques
Question d’ordre technique sur : 3D-FH92930 N-Hydroxy-4-(Trifluoromethyl)-Benzenecarboximidamide
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages